Correction to "Biomimetic Ginsenoside Rb1 and Probucol Co-Assembled Nanoparticles for Targeted Atherosclerosis Therapy via Inhibition of Oxidative Stress, Inflammation, and Lipid Deposition"
ACS Nano. 2025 Nov 18;19(45):39531.
doi: 10.1021/acsnano.5c17048.
Epub 2025 Nov 9.